
GLP1 RAs and the Risk of Non-Arteritic Anterior Ischemic Optic Neuropathy
19 Nov 2026 ยท 25:01
MedicineDescription
Dr. Drew Carey is joined by Dr. Sarah W. DeParis and Dr. John J. Chen, authors from the Consensus Statement by the North American Neuro-Ophthalmology Society and the American Academy of Ophthalmology on Glucagon-Like Peptide-1 Receptor Agonists and the Risk of Non-Arteritic Anterior Ischemic Optic Neuropathy, published in Ophthalmology.
DeParis S, et al. Glucagon-Like Peptide-1 Receptor Agonists and the Risk of Non-Arteritic Anterior Ischemic Optic Neuropathy: A Consensus Statement by the North American Neuro-Ophthalmology Society and the American Academy of Ophthalmology. Ophthalmology, 2026; Volume 133, Issue 8 1029-1035.
For more information see "Here's What You Need To Know About the FDA's New GLP-1 Warning" from the Academy.
AAO 2026 may be over in New Orleans, but the learning continues through March 2027. Access more than 300 expert-led sessions on your schedule, from wherever you are. Experience the discussions shaping ophthalmology alongside clinical education, posters, Subspecialty Day and Cataract Spotlight. Earn CME credits and watch sessions now. Get access today at https://www.aao.org/pod-virtual
Comments
No comments yet โ be the first to write one.